{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:06:22Z","timestamp":1793286382381,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41401-021-00714-4","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T10:04:57Z","timestamp":1626343497000},"page":"771-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation"],"prefix":"10.1038","volume":"43","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ge","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-xian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-dong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-wen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"714_CR1","doi-asserted-by":"crossref","first-page":"112687","DOI":"10.1016\/j.ejmech.2020.112687","volume":"205","author":"L Zheng","year":"2020","unstructured":"Zheng L, Zhang L, Huang J, Nandakumar KS, Liu S, Cheng K. Potential treatment methods targeting 2019-nCoV infection. Eur J Med Chem. 2020;205:112687.","journal-title":"Eur J Med Chem"},{"key":"714_CR2","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1073\/pnas.57.4.933","volume":"57","author":"K McIntosh","year":"1967","unstructured":"McIntosh K, Dees JH, Becker WB, Kapikian AZ, Chanock RM. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA. 1967;57:933\u201340.","journal-title":"Proc Natl Acad Sci USA"},{"key":"714_CR3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrmicro2147","volume":"7","author":"S Perlman","year":"2009","unstructured":"Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol. 2009;7:439\u201350.","journal-title":"Nat Rev Microbiol"},{"key":"714_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507\u201313.","journal-title":"Lancet"},{"key":"714_CR5","doi-asserted-by":"crossref","first-page":"102200","DOI":"10.1016\/j.scr.2021.102200","volume":"51","author":"YP Li","year":"2021","unstructured":"Li YP, Ma Y, Wang N, Jin ZB. Eyes on coronavirus. Stem Cell Res. 2021;51:102200.","journal-title":"Stem Cell Res"},{"key":"714_CR6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"D Wang","year":"2020","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061\u20139.","journal-title":"JAMA"},{"key":"714_CR7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497\u2013506.","journal-title":"Lancet"},{"key":"714_CR8","doi-asserted-by":"crossref","first-page":"138996","DOI":"10.1016\/j.scitotenv.2020.138996","volume":"730","author":"T Acter","year":"2020","unstructured":"Acter T, Uddin N, Das J, Akhter A, Choudhury TR, Kim S. Evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as coronavirus disease 2019 (COVID-19) pandemic: a global health emergency. Sci Total Environ. 2020;730:138996.","journal-title":"Sci Total Environ"},{"key":"714_CR9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(03)13412-5","volume":"361","author":"J Peiris","year":"2003","unstructured":"Peiris J, Chu C, Cheng V, Chan K, Hung I, Poon L, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361:1767\u201372.","journal-title":"Lancet"},{"key":"714_CR10","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.it.2020.10.004","volume":"41","author":"AG Harrison","year":"2020","unstructured":"Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 transmission and pathogenesis. Trends Immunol. 2020;41:1100\u201315.","journal-title":"Trends Immunol"},{"key":"714_CR11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Z Xu","year":"2020","unstructured":"Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8:420\u20132.","journal-title":"Lancet Respir Med"},{"key":"714_CR12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","volume":"319","author":"E Fan","year":"2018","unstructured":"Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA. 2018;319:698\u2013710.","journal-title":"JAMA"},{"key":"714_CR13","first-page":"183","volume":"167","author":"TJ Standiford","year":"2016","unstructured":"Standiford TJ, Ward PA. Therapeutic targeting of acute lung injury and acute respiratory distress syndrome. Transl Res J Lab Clin Med. 2016;167:183\u201391.","journal-title":"Transl Res J Lab Clin Med"},{"key":"714_CR14","doi-asserted-by":"crossref","unstructured":"Chan JF, Kok KH. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020; 9:221\u201336.","DOI":"10.1080\/22221751.2020.1719902"},{"key":"714_CR15","doi-asserted-by":"crossref","unstructured":"Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418\u201323.","DOI":"10.1002\/jmv.25681"},{"key":"714_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","volume":"27","author":"A Wu","year":"2020","unstructured":"Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host microbe. 2020;27:325\u20138.","journal-title":"Cell host microbe"},{"key":"714_CR17","volume":"7","author":"YH Jin","year":"2020","unstructured":"Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, et al. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res. 2020;7:4.","journal-title":"Mil Med Res"},{"key":"714_CR18","doi-asserted-by":"crossref","first-page":"172710","DOI":"10.1016\/j.ejphar.2019.172710","volume":"864","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zhang Q, Liu G, Zhang N. Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu. Eur J Pharmacol. 2019;864:172710.","journal-title":"Eur J Pharmacol"},{"key":"714_CR19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3389\/fphar.2018.01445","volume":"9","author":"XY Bao","year":"2018","unstructured":"Bao XY, Zheng Q, Tong Q, Zhu PC, Zhuang Z, Zheng GQ, et al. Danshensu for myocardial ischemic injury: preclinical evidence and novel methodology of quality assessment tool. Front Pharmacol. 2018;9:1445.","journal-title":"Front Pharmacol"},{"key":"714_CR20","doi-asserted-by":"crossref","first-page":"115434","DOI":"10.18632\/oncotarget.23272","volume":"8","author":"H Xu","year":"2017","unstructured":"Xu H, Liu W, Liu T, Su N, Guo C, Feng X, et al. Synergistic neuroprotective effects of Danshensu and hydroxysafflor yellow A on cerebral ischemia-reperfusion injury in rats. Oncotarget. 2017;8:115434\u201343.","journal-title":"Oncotarget"},{"key":"714_CR21","doi-asserted-by":"crossref","first-page":"173352","DOI":"10.1016\/j.ejphar.2020.173352","volume":"883","author":"L Jiang","year":"2020","unstructured":"Jiang L, Wang J, Ju J, Dai J. Salvianolic acid B and sodium tanshinone II A sulfonate prevent pulmonary fibrosis through anti-inflammatory and anti-fibrotic process. Eur J Pharmacol. 2020;883:173352.","journal-title":"Eur J Pharmacol"},{"key":"714_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.phymed.2018.09.170","volume":"52","author":"J Luo","year":"2019","unstructured":"Luo J, Zhang L, Zhang X, Long Y, Zou F, Yan C, et al. Protective effects and active ingredients of Salvia miltiorrhiza Bunge extracts on airway responsiveness, inflammation and remodeling in mice with ovalbumin-induced allergic asthma. Phytomedicine. 2019;52:168\u201377.","journal-title":"Phytomedicine"},{"key":"714_CR23","doi-asserted-by":"crossref","unstructured":"Yang C, Pan X, Xu X, Cheng C, Huang Y, Li L, et al. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein. Signal Transduct Target Ther. 2020; 5: 220.","DOI":"10.1038\/s41392-020-00325-1"},{"key":"714_CR24","doi-asserted-by":"crossref","first-page":"104350","DOI":"10.1016\/j.yexmp.2019.104350","volume":"113","author":"R Ye","year":"2020","unstructured":"Ye R, Liu Z. ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway. Exp Mol Pathol. 2020;113:104350.","journal-title":"Exp Mol Pathol"},{"key":"714_CR25","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fphar.2017.00397","volume":"8","author":"CK Chan","year":"2017","unstructured":"Chan CK, Tan LT, Andy SN, Kamarudin MNA, Goh BH, Kadir HA. Anti-neuroinflammatory activity of Elephantopus scaber L. via activation of Nrf2\/HO-1 signaling and inhibition of p38 MAPK pathway in LPS-induced microglia BV-2 cells. Front Pharmacol. 2017;8:397.","journal-title":"Front Pharmaco"},{"key":"714_CR26","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/toxsci\/kfz234","volume":"173","author":"P Wang","year":"2020","unstructured":"Wang P, Zhang L, Liao Y, Du J, Xu M, Zhao W, et al. Effect of Intratracheal instillation of ZnO nanoparticles on acute lung inflammation induced by lipopolysaccharides in mice. Toxicol Sci. 2020;173:373\u201386.","journal-title":"Toxicol Sci."},{"key":"714_CR27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.biopha.2018.04.162","volume":"103","author":"W Wang","year":"2018","unstructured":"Wang W, Wu L, Li Q, Zhang Z, Xu L, Lin C, et al. Madecassoside prevents acute liver failure in LPS\/D-GalN-induced mice by inhibiting p38\/NF-\u03baB and activating Nrf2\/HO-1 signaling. Biomed Pharmacother. 2018;103:1137\u201345.","journal-title":"Biomed Pharmacother"},{"key":"714_CR28","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/os.12808","volume":"12","author":"L Li","year":"2020","unstructured":"Li L, Liu Y, Zhao X, Qi C, Zhang Y, Zhang Y, et al. Salvianic acid A sodium promotes the recovery of motor function after spinal cord injury in rats by reducing microglia inflammation through regulating MIP2\/Vdac1\/Ndufa12 signaling axis. Orthop Surg. 2020;12:1971\u20139.","journal-title":"Orthop Surg"},{"key":"714_CR29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11418-019-01379-4","volume":"74","author":"Y Li","year":"2020","unstructured":"Li Y, Chen H, Yang Y, Niu M, Wang J, Wu Y, et al. Danshen formula granule and salvianic acid A alleviate ethanol-induced neurotoxicity. J Nat Med. 2020;74:399\u2013408.","journal-title":"J Nat Med"},{"key":"714_CR30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1038\/s41401-019-0265-1","volume":"40","author":"D Jia","year":"2019","unstructured":"Jia D, Zhang CZ, Qiu Y, Chen XF, Jia L, Chen AF, et al. Cardioprotective mechanisms of salvianic acid A sodium in rats with myocardial infarction based on proteome and transcriptome analysis. Acta Pharmacol Sin. 2019;40:1513\u201322.","journal-title":"Acta Pharmacol Sin"},{"key":"714_CR31","doi-asserted-by":"crossref","unstructured":"Bourgonje A. R., Abdulle A. E., Timens W. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol. 2020; 251: 228-48.","DOI":"10.1002\/path.5471"},{"key":"714_CR32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","volume":"9","author":"J Nie","year":"2020","unstructured":"Nie J, Li Q, Wu J, Zhao C, Hao H, Liu H, et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2. Emerg Microbes Infect. 2020;9:680\u20136.","journal-title":"Emerg Microbes Infect"},{"key":"714_CR33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-1759(96)00236-0","volume":"202","author":"RJ Szarka","year":"1997","unstructured":"Szarka RJ, Wang N, Gordon L, Nation PN, Smith RH. A murine model of pulmonary damage induced by lipopolysaccharide via intranasal instillation. J Immunol Methods. 1997;202:49\u201357.","journal-title":"J Immunol Methods"},{"key":"714_CR34","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(20)30920-X","volume":"395","author":"H Li","year":"2020","unstructured":"Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020;395:1517\u201320.","journal-title":"Lancet"},{"key":"714_CR35","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/0092-8674(94)90278-X","volume":"78","author":"NW Freshney","year":"1994","unstructured":"Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell. 1994;78:1039\u201349.","journal-title":"Cell"},{"key":"714_CR36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/372739a0","volume":"372","author":"JC Lee","year":"1994","unstructured":"Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739\u201346.","journal-title":"Nature"},{"key":"714_CR37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.7914033","volume":"265","author":"J Han","year":"1994","unstructured":"Han J, Lee JD, Bibbs L, Ulevitch RJA. MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994;265:808\u201311.","journal-title":"Science"},{"key":"714_CR38","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/15701611113116660160","volume":"13","author":"AN Seneviratne","year":"2015","unstructured":"Seneviratne AN, Monaco C. Role of inflammatory cells and toll-like receptors in atherosclerosis. Curr Vasc Pharmacol. 2015;13:146\u201360.","journal-title":"Curr Vasc Pharmacol"},{"key":"714_CR39","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.intimp.2011.12.014","volume":"12","author":"XL Yang","year":"2012","unstructured":"Yang XL, Guo TK, Wang YH, Huang YH, Liu X, Wang XX, et al. Ginsenoside Rd attenuates the inflammatory response via modulating p38 and JNK signaling pathways in rats with TNBS-induced relapsing colitis. Int Immunopharmacol. 2012;12:408\u201314.","journal-title":"Int Immunopharmacol"},{"key":"714_CR40","doi-asserted-by":"crossref","first-page":"e97523","DOI":"10.1371\/journal.pone.0097523","volume":"9","author":"S Wang","year":"2014","unstructured":"Wang S, Hibberd ML, Pettersson S, Lee YK. Enterococcus faecalis from healthy infants modulates inflammation through MAPK signaling pathways. PLoS One. 2014;9:e97523.","journal-title":"PLoS One"},{"key":"714_CR41","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","volume":"2","author":"Q Li","year":"2002","unstructured":"Li Q, Verma IM. NF-\u03baB regulation in the immune system. Nat Rev Immunol. 2002;2:725\u201334.","journal-title":"Nat Rev Immunol"},{"key":"714_CR42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/gast.2002.34161","volume":"123","author":"N Enomoto","year":"2002","unstructured":"Enomoto N, Takei Y, Hirose M, Ikejima K, Miwa H, Kitamura T, Sato N. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production. Gastroenterology. 2002;123:291\u2013300.","journal-title":"Gastroenterology"},{"key":"714_CR43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes PJ, Karin M. Nuclear factor-\u03baB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med. 1997;336:1066\u201371.","journal-title":"N Engl J Med"},{"key":"714_CR44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI11830","volume":"107","author":"PP Tak","year":"2001","unstructured":"Tak PP, Firestein GS. NF-\u03baB: a key role in inflammatory diseases. J Clin Invest. 2001;107:7\u201311.","journal-title":"J Clin Invest."},{"key":"714_CR45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Camandola S. NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107:247\u201354.","journal-title":"J Clin Invest"},{"key":"714_CR46","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.vph.2006.10.011","volume":"46","author":"FF Lam","year":"2007","unstructured":"Lam FF, Yeung JH, Chan KM, Or PM. Relaxant effects of danshen aqueous extract and its constituent danshensu on rat coronary artery are mediated by inhibition of calcium channels. Vasc Pharmacol. 2007;46:271\u20137.","journal-title":"Vasc Pharmacol"},{"key":"714_CR47","doi-asserted-by":"crossref","unstructured":"Matsuyama T, Kubli SP, Yoshinaga SK, Pfeffer K. An aberrant STAT pathway is central to COVID-19. Cell Death Differ. 2020; 27:3209\u201325.","DOI":"10.1038\/s41418-020-00633-7"},{"key":"714_CR48","doi-asserted-by":"crossref","unstructured":"Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020; 581: 221\u20134.","DOI":"10.1038\/s41586-020-2179-y"},{"key":"714_CR49","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","volume":"181","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang Y, Wu L, Niu S, Song C, Zhang Z, Lu G, Qiao C, Hu Y, Yuen KY, Wang Q, Zhou H, Yan J, Qi J. Structural and functional basis of SARS-CoV-2 entry by using human ACE2. Cell. 2020;181:894\u2013904.e9.","journal-title":"Cell"},{"key":"714_CR50","doi-asserted-by":"crossref","unstructured":"Wan Y., Shang J., Graham R., Baric R. S., Li F. Receptor recognition by the novel coronavirus from wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J. Virol. 2020;94:e00127\u201320.","DOI":"10.1128\/JVI.00127-20"},{"key":"714_CR51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/CIRCULATIONAHA.120.047049","volume":"142","author":"K Wang","year":"2020","unstructured":"Wang K, Gheblawi M, Oudit GY. Angiotensin converting enzyme 2: a double-edged sword. Circulation. 2020;142:426\u20138.","journal-title":"Circulation"},{"key":"714_CR52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"AC Walls","year":"2020","unstructured":"Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281\u201392.e6.","journal-title":"Cell"},{"key":"714_CR53","doi-asserted-by":"crossref","unstructured":"Yan R., Zhang Y. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020; 367:1444-8.","DOI":"10.1126\/science.abb2762"},{"key":"714_CR54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","volume":"436","author":"Y Imai","year":"2005","unstructured":"Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112\u20136.","journal-title":"Nature"},{"key":"714_CR55","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.burns.2015.04.010","volume":"41","author":"Z Yilin","year":"2015","unstructured":"Yilin Z, Yandong N, Faguang J. Role of angiotensin-converting enzyme (ACE) and ACE2 in a rat model of smoke inhalation induced acute respiratory distress syndrome. Burns. 2015;41:1468\u201377.","journal-title":"Burns."},{"key":"714_CR56","doi-asserted-by":"crossref","unstructured":"Hansen J, Baum A. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science. 2020;369:1010\u20134.","DOI":"10.1126\/science.abd0827"},{"key":"714_CR57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","volume":"11","author":"K Kuba","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11:875\u20139.","journal-title":"Nat Med"},{"key":"714_CR58","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","volume":"126","author":"M Gheblawi","year":"2020","unstructured":"Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456\u201374.","journal-title":"Circ Res"},{"key":"714_CR59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00109-012-0859-2","volume":"90","author":"GJ Rey-Parra","year":"2012","unstructured":"Rey-Parra GJ, Vadivel A, Coltan L, Hall A, Eaton F, Schuster M, et al. Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury. J Mol Med. 2012;90:637\u201347.","journal-title":"J Mol Med"},{"key":"714_CR60","doi-asserted-by":"crossref","unstructured":"Hemnes AR, Rathinasabapathy A, Austin EA, Brittain EL, Carrier EJ, Chen X, et al. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. Eur Respir J. 2018;51:1702638.","DOI":"10.1183\/13993003.02638-2017"},{"key":"714_CR61","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/s13054-017-1823-x","volume":"21","author":"A Khan","year":"2017","unstructured":"Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care (Lond, Engl). 2017;21:234.","journal-title":"Crit Care (Lond, Engl)"},{"key":"714_CR62","doi-asserted-by":"crossref","first-page":"10505","DOI":"10.1096\/fj.202001020R","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, Kaplan N, Wysocki J, Yang W, Lu K, Peng H, et al. The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation. FASEB J. 2020;34:10505\u201315.","journal-title":"FASEB J"},{"key":"714_CR63","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s11010-021-04054-z","volume":"476","author":"SC Tyagi","year":"2021","unstructured":"Tyagi SC, Singh M. Multi-organ damage by Covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage. Mol Cell Biochem. 2021;476:1891\u20135.","journal-title":"Mol Cell Biochem"},{"key":"714_CR64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1042\/CS20130400","volume":"126","author":"CM Ferrario","year":"2014","unstructured":"Ferrario CM, Ahmad S, Nagata S, Simington SW, Varagic J, Kon N, et al. An evolving story of angiotensin-II-forming pathways in rodents and humans. Clin Sci. 2014;126:461\u20139.","journal-title":"Clin Sci"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00714-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00714-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:37:10Z","timestamp":1648820230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-021-00714-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1038\/s41401-021-00714-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}